GTC
MRNA icon

Ghost Tree Capital’s Moderna MRNA Stock Holding History

Ghost Tree Capital’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-5,300
Closed -$2.04M – 65
2021
Q3 		$2.04M Buy
5,300
+1,300
+33% +$479K 0.6% 49
2021
Q2 		$940K Buy
+4,000
New +$715K 0.26% 50
2020
Q4 		– Sell
-10,000
Closed -$1.01M – 51
2020
Q3 		$708K Hold
10,000
– – 0.2% 42
2020
Q2 		$642K Buy
+10,000
New +$548K 0.17% 42

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Ghost Tree Capital's MRNA Position: Q4 2021 in Review

Ghost Tree Capital sold out of Moderna (MRNA) in Q4 2021, closing a stake of 5,300 shares — an estimated $2.04M sold.

Ghost Tree Capital first reported a position in MRNA in Q2 2020 and held it in 4 quarters. The position peaked at $2.04M in Q3 2021. 1,109 funds tracked by Wall St. Rank hold MRNA as of Q4 2021.

  • Ghost Tree Capital reported no remaining Moderna position as of Q4 2021 after selling out during the quarter.
  • Ghost Tree Capital sold 5,300 Moderna shares in Q4 2021, an estimated $2.04M.
  • Ghost Tree Capital first reported a position in Moderna in Q2 2020 and held it in 4 quarters.
  • Ghost Tree Capital's Moderna position peaked at $2.04M in Q3 2021.
  • 1,109 funds tracked by Wall St. Rank held Moderna as of Q4 2021.

Based on Ghost Tree Capital's 13F filing for Q4 2021, filed 16 Feb 2022.